Background illustration for clinical trials search

Paid Clinical Trials Raleigh

Discover 1,609 paid clinical trials in Raleigh, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Phase 2a Proof of Concept Open-Label, Randomized, Controlled Study to Evaluate the Safety and Efficacy of MDI-1228-mesylate Gel Compared With Standard of Care Alone in Patients With Diabetic Foot Ulcers

for
Diabetic Foot Ulcer
Location: Durham NC
Sponsor: Zhuhai Rui-Inno Pharmaceutical Technology Co., Ltd.

Sex: All

Age: 18 - 70+

Code: NCT06852976

Phase2, Recruiting

Aimovig Pregnancy Exposure Registry

for
Migraine
Location: Durham NC
Sponsor: Amgen

Sex: Female

Age: 18 - 70+

Code: NCT06150781

Recruiting

Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)

for
Multiple Sclerosis
Location: Durham NC, Aurora CO
Sponsor: Biogen

Sex: Female

Age: 0+

Code: NCT05658497

Recruiting

A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)

for
Irritable Bowel Syndrome
Location: Rocky Mount NC, Fayetteville NC, Greenville NC,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07519395

Phase2, Recruiting

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

for
Multiple Myeloma
Location: Wilson NC, Chapel Hill NC, Chattanooga TN, Canton OH,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT05714839

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)

for
Neoplasms, Lung
Location: Wilson NC, Toronto, Ottawa, Montreal, Los Angeles CA
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07099898

Phase3, Recruiting

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

for
Metabolic Dysfunction-Associated Steatohepatitis,
Location: Wilson NC, Fayetteville NC, Richmond VA, Baltimore MD,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT06920043

Phase2, Recruiting

Cochlear Implants in Young Children With SSD

for
Single Sided Deafness, Unilateral Deafness,
Location: Durham NC
Sponsor: University of North Carolina, Chapel Hill

Sex: All

Age: 0 - 5

Code: NCT05775367

Recruiting

A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)

for
Lipoprotein(a)
Location: Durham NC, Manassas VA, Kingsport TN, Rockville MD,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07614984

Phase2, Recruiting

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

for
Hypercholesterolemia
Location: Durham NC, Wilmington NC, Charlottesville VA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07477704

Phase2, Recruiting

A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris

for
Lichen Planopilaris
Location: Durham NC, Roanoke VA, Richmond VA, Norfolk VA,
Sponsor: Priovant Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07532603

Phase2, Phase3, Recruiting

NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

for
Coronavirus Infection, Severe Acute Respiratory Infection,
Location: Durham NC, Washington DC, Bethesda MD, Baltimore MD,
Sponsor: Biomed Industries, Inc.

Sex: All

Age: 18 - 70+

Code: NCT04452565

Phase2, Phase3, Recruiting

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

for
Colonic Neoplasms, Neoplasms, Colon
Location: Durham NC, Richmond VA, Bethesda MD, Detroit MI,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT05855200

Phase3, Recruiting

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

for
Lung Diseases, Interstitial
Location: Durham NC, Gainesville FL, Philadelphia PA, New York NY,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06572384

Phase3, Recruiting

A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

for
HIV Infections
Location: Durham NC, Greensboro NC, Wilmington NC, Charlotte NC,
Sponsor: ViiV Healthcare

Sex: All

Age: 18+

Code: NCT07202546

Phase2, Recruiting

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

for
Gastrointestinal Neoplasms
Location: Durham NC, Charlotte NC, Charlottesville VA,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07218926

Phase3, Recruiting

A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)

for
Tumours, Gynecological
Location: Durham NC, Columbus OH, Rochester NY, Toronto, Montreal,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06796907

Phase1, Phase2, Recruiting

A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)

for
Gastrointestinal Neoplasms
Location: Durham NC, New York NY, Toronto, Montreal, Madison WI,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06885034

Phase1, Phase2, Recruiting

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

for
Liver Diseases, Alcoholic
Location: Chapel Hill NC, Richmond VA, Detroit MI,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70

Code: NCT06613698

Phase2, Recruiting

Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout

for
Hyperuricemia, Gout
Location: Durham NC
Sponsor: Pharmos

Sex: All

Age: 18 - 65

Code: NCT01519687

Phase2, Recruiting